Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NLS Pharma Group

nlspharma.com

Latest From NLS Pharma Group

Pipeline Watch: Topline Readouts With Keytruda, Cosentyx And Zepsyre

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Pipeline Watch: Top-Line Fremanezumab, Ramucirumab, Bictegravir Results

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

NLS Pharma Pins Hopes On Ex-Obesity Drug For ADHD

Emerging Company Profile: NLS Pharma wants to develop novel treatments for ADHD, sleep disorders and cognitive impairments. Its big hope is mazindol CR, for which it has just announced promising Phase II data. The firm explains what is next.

Research & Development Research and Development Strategies

Pipeline Watch: Top-Line Lanadelumab, Inotersen, Durvalumab Results

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • NeuroLifeSciences SAS
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • NLS Pharma Group
  • Senior Management
  • Alex Zwyer, CEO
    Eric Konofal , MD, PhD, Head, Drug Disc.
    Sharon Keys, Head, Reg. Affairs
    Nelson Handal, MD, CMO
    Herve Girsault, Head, M&A & Bus. Dev.
    Bruno Figadère i, PhD, Head, R&D
  • Contact Info
  • NLS Pharma Group
    Phone: 41 618 80 00
    Alter Postplatz 2
    Stans NW, CH-6370
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register